ENTRY       D11553            Mixture   Drug
NAME        Lidocaine and tetracaine;
            Pliaglis (TN);
            Synera (TN)
PRODUCT     PLIAGLIS (Oba Pharmaceuticals)
            PLIAGLIS (Taro Pharmaceuticals U.S.A.)
  GENERIC   LIDOCAINE AND TETRACAINE (Innovida Pharmaceutique Corporation)
COMPONENT   Lidocaine [DR:D00358], Tetracaine [DR:D00551]
CLASS       Metabolizing enzyme substrate
             DG01892  CYP1A2 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      Product: D11553<US>
EFFICACY    Analgesic (local, topical)
COMMENT     Lidocaine is metabolized by CYP1A2 with some contribution from CYP3A4.
METABOLISM  Enzyme: CYP1A2 [HSA:1544]; CYP3A4 [HSA:1576]
INTERACTION  
BRITE       USP drug classification [BR:br08302]
             Anesthetics
              Local Anesthetics
               Lidocaine/ Tetracaine
                D11553  Lidocaine and tetracaine
            Drug groups [BR:br08330]
             Metabolizing enzyme substrate
              DG01892  CYP1A2 substrate
               D11553  Lidocaine and tetracaine
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                D11553  Lidocaine and tetracaine
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11553
DBLINKS     CAS: 444093-81-6
            PubChem: 384585529
///
